Zhu, Eric, Jason Oh, Carl Dambkowski, and Hussam Shaheen. “APG777, a High-Affinity Humanized IgG1 Monoclonal Antibody Targeting IL-13, Demonstrates Prolonged Half-Life in Non-Human Primates”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s315. Accessed July 16, 2024. https://jofskin.org/index.php/skin/article/view/2393.